Deutsche Apotheker- und Ärztebank (apoBank) completed the first six months of 2014 with a net profit of €24.9 million, thus exceeding the level of the same period in the previous year (30 June 2013: €24.1 million). The operating result, i.e. profit before risk provisioning, rose by 12.1 percent, to €203.5 million. With 376,000 customers, apoBank further consolidated its high level of market penetration (31 December 2013: 373,000 customers), benefiting here in particular from its new customer support concept.
"We also set ourselves the aim of growing the investment business", said Herbert Pfennig, Spokesman of the Board of Directors of apoBank. "We have been very successful in this thanks to our new structure and our integrated advisory services." apoBank recently aligned its sales concept even more closely to the specific needs of health care professionals. Its specialists provide advice that is tailored to customers’ individual life phases.
The phase-out of the structured financial products also went well: In May 2014 - earlier than planned - apoBank completed the phase-out of this sub-portfolio.